Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Naquotinib |
| Trade Name | |
| Synonyms | ASP8273 |
| Drug Descriptions |
Naquotinib (ASP8273) is a third-generation EGFR inhibitor that binds mutant forms of EGFR, including T790M, and also inhibits AXL, thus may lead to growth inhibition in tumor cells (PMID: 29467275, PMID: 31092564). |
| DrugClasses | AXL Inhibitor 30 EGFR Inhibitor 3rd gen 28 |
| CAS Registry Number | 1448232-80-1 |
| NCIT ID | C115110 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| JBJ-04-125-02 + Naquotinib | JBJ-04-125-02 Naquotinib | 0 | 0 |
| Naquotinib | Naquotinib | 0 | 5 |